Position in BCRX
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$26,040,270
+$19,702 QoQ
Shares Held
2,604,027
-4.7% QoQ
Ownership
1.02%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#23
of 316 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 31%
Shared 0%
None 69%
Common Shares in BCRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Fisher Asset Management, LLC holds $131,969,402 across 8 Drug Manufacturers - Specialty & Generic names. BCRX ranks #1 (19.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BCRX |
Biocryst Pharmaceuticals Inc
This page
|
2,604,027 | $26,040,270 | |
| 2 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
398,266 | $25,469,110 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
135,104 | $22,770,428 | |
| 4 | ALKS |
Alkermes plc.
|
419,102 | $21,960,944 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
33,836 | $18,333,359 | |
| 6 | PBH |
Prestige Consumer Healthcare Inc.
|
247,474 | $11,698,095 | |
| 7 | HLN |
Haleon plc
|
329,891 | $3,077,883 | |
| 8 | RDY |
Dr Reddys Laboratories Ltd
|
180,767 | $2,619,313 |
All Filings in BCRX
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $26,040,270 | 2,604,027 | Shares | Defined | 2026-08-04 | |
| 2026-03-31 | $26,020,568 | 2,733,253 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $19,247,022 | 2,467,567 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $19,982,162 | 2,632,696 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $24,931,101 | 2,782,489 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $22,891,027 | 3,052,137 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $23,933,279 | 3,182,617 | Shares | Defined | 2025-02-05 | |
| 2024-09-30 | $25,369,271 | 3,338,062 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $17,654,424 | 2,856,703 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $14,653,864 | 2,884,619 | Shares | Defined | 2024-05-09 | |
| 2023-12-31 | $17,278,568 | 2,884,569 | Shares | Defined | 2024-03-05 | |
| 2023-09-30 | $22,551,208 | 3,185,199 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $30,444,853 | 4,324,553 | Shares | Sole | 2023-12-12 | |
| 2023-03-31 | $35,806,922 | 4,293,396 | Shares | Sole | 2023-12-12 | |
| 2022-12-31 | $50,869,188 | 4,431,114 | Shares | Defined | 2023-02-03 | |
| 2022-09-30 | $65,064,447 | 5,163,845 | Shares | Defined | 2022-11-08 | |
| 2022-06-30 | $55,194,050 | 5,216,829 | Shares | Defined | 2022-08-09 | |
| 2022-03-31 | $64,825,741 | 3,986,823 | Shares | Defined | 2022-05-05 | |
| 2021-12-31 | $56,744,170 | 4,097,052 | Shares | Defined | 2022-02-02 | |
| 2021-09-30 | $43,190,788 | 3,005,622 | Shares | Defined | 2021-10-26 | |
| 2021-06-30 | $31,797,562 | 2,011,231 | Shares | Defined | 2021-07-27 | |
| No filing history on record for this holder in this stock. | ||||||